CD28 blockade induces division-dependent downregulation of interleukin-2 receptor alpha

Transpl Immunol. 2011 Jan 15;24(2):94-9. doi: 10.1016/j.trim.2010.11.002. Epub 2010 Nov 10.

Abstract

Background: Blockade of T cell costimulatory molecules represents a promising new method of attenuating donor-reactive T cell responses to promote graft survival following transplantation. However, recent studies in murine models have shown the presence of an initial high frequency of naïve donor-reactive T cells may render this strategy ineffective.

Methods: In this report, we examined the phenotypic changes associated with CD28 blockade on T cells stimulated at increasing precursor frequencies in vitro.

Results: We found that treatment with the CD28 blocker CTLA-4 Ig resulted in downregulation of the alpha chain of the IL-2 receptor (CD25) in a division-dependent manner. Significantly, blockade of the CD28 pathway was more effective in down-regulating CD25 when the donor-reactive T cell population was present at low as compared to high precursor frequency.

Conclusions: These results imply that treatment with CD28 blockers and anti-CD25 mAbs may cooperate in promoting graft survival under conditions of low MHC matching where the donor-reactive T cell precursor frequency is high.

MeSH terms

  • Abatacept
  • Animals
  • Antibodies, Monoclonal
  • CD28 Antigens / immunology*
  • CD28 Antigens / metabolism*
  • Cell Division*
  • Flow Cytometry
  • Gene Expression Regulation
  • Graft Survival / immunology
  • Immunoconjugates / immunology
  • Immunoconjugates / pharmacology*
  • Interleukin-2 / pharmacology
  • Interleukin-2 Receptor alpha Subunit / genetics*
  • Interleukin-2 Receptor alpha Subunit / immunology
  • Interleukin-2 Receptor alpha Subunit / metabolism*
  • Mice
  • Mice, Transgenic
  • Signal Transduction
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Monoclonal
  • CD28 Antigens
  • Immunoconjugates
  • Interleukin-2
  • Interleukin-2 Receptor alpha Subunit
  • Abatacept